BioProtect ltd. Revenue and Competitors
Estimated Revenue & Valuation
- BioProtect ltd.'s estimated annual revenue is currently $25.4M per year.
- BioProtect ltd.'s estimated revenue per employee is $251,000
Employee Data
- BioProtect ltd. has 101 Employees.
- BioProtect ltd. grew their employee count by 49% last year.
BioProtect ltd.'s People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Operating Officer | Reveal Email/Phone |
2 | SVP Marketing & Education | Reveal Email/Phone |
3 | VP Clinical Affairs at BioProtect Ltd | Reveal Email/Phone |
4 | Director Quality Assurance & Regulatory Affairs | Reveal Email/Phone |
5 | Senior Director QA/RA | Reveal Email/Phone |
6 | Director Quality Assurance & Regulatory Affairs | Reveal Email/Phone |
7 | Clinical Science Manager | Reveal Email/Phone |
8 | Human Resources Manager | Reveal Email/Phone |
9 | QA/RA Manager | Reveal Email/Phone |
10 | Manufacturing Manager | Reveal Email/Phone |
BioProtect ltd. Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $6.1M | 49 | -18% | $10M | N/A |
#2 | $30.4M | 121 | 29% | N/A | N/A |
#3 | $139.8M | 913 | -3% | $200K | N/A |
#4 | $84.1M | 0 | N/A | $1.2M | N/A |
#5 | $43.4M | 173 | 30% | N/A | N/A |
#6 | $64.5M | 257 | 12% | N/A | N/A |
#7 | $64.3M | 205 | 26% | $129.6M | N/A |
#8 | $19.6M | 78 | -7% | N/A | N/A |
#9 | $65.8M | 262 | 7% | N/A | N/A |
#10 | $73.7M | 235 | 20% | $115.5M | N/A |
What Is BioProtect ltd.?
BioProtect is a leader in radiation protection technology. We offer spacers protecting healthy tissue during radiation oncology treatments, based on proprietary biodegradable balloon technology. The balloons suit a wide range of clinical applications in the fields of oncology and general surgery. The company's first product, the BioProtect Balloon Implant, protects healthy tissue in patients undergoing radiation therapy for prostate cancer. The balloon spacer enables safe high-dose radiation therapy (including dose escalation and hypofractionation), dramatically decreasing the probability of serious and chronic radiation side effects while improving biochemical tumor control.
keywords:N/A
N/A
Total Funding
101
Number of Employees
$25.4M
Revenue (est)
49%
Employee Growth %
N/A
Valuation
N/A
Accelerator
BioProtect ltd. News
... Arbico, Applied Bio-nomics, ENTOCARE, BioBee, Anatis Bioprotection, Rentokil, Beneficial insectary, F.A.R, Kenya Biologics Ltd., Xilema,...